Table 5.
Characteristics of those responding "YES" to Q3 "shortness of breath", Q5 "asthma", or Q6 "treatment of asthma", according to the ECRHS main questionnaire (n = 146)
| male (n = 84) |
female (n = 62) |
ALL n = 146 |
p | |
|---|---|---|---|---|
| Age in years, mean (SD) | 30.8 (16.7) | 33.9 (16.2) | 32.6 (16.4) | 0.263 |
| Age band, n (%) | 0.711 | |||
| • 19 yr or less | 22 (26.2%) | 17 (24.4%) | 39 (26.7%) | |
| • 20 to 44 yr | 38 (45.2%) | 31 (50.0%) | 69 (47.3%) | |
| • 45 yr or more | 24 (28.6%) | 14 (22.6%) | 38 (26.0%) | |
| ECRHS screening questionnaire symptoms within the last 12 months, n (%) | ||||
| Wheezing/whistling | 59 (70.2%) | 49 (76.6%) | 108 (73.0%) | 0.457 |
| Wheezing with breathlessness | 53 (63.1%) | 45 (70.3%) | 98 (66.2%) | 0.649 |
| Wheezzing without a cold | 52 (61.9%) | 34 (53.1%) | 86 (58.1%) | 0.037* |
| Woken up with chest tightness | 56 (66.7%) | 38 (59.4%) | 94 (63.5%) | 0.392 |
| Woken up by shortness of breath | 67 (79.8%) | 44 (68.8%) | 111 (75.0%) | 0.131 |
| Woken up by an attack of coughing | 54 (64.3%) | 44 (68.5%) | 98 (66.2%) | 0.603 |
| Attack of asthma | 52 (61.9%) | 47 (73.4%) | 99 (66.9%) | 0.161 |
| Currently taking asthma medications | 56 (66.7%) | 42 (65.6%) | 98 (66.2%) | 1.000 |
| Nasal allergies (including hay fever) | 29 (34.5%) | 27 (42.2%) | 56 (37.8%) | 0.394 |
"*" Significant p-value